公司概覽
業務類別 Biotechnology
業務概覽 Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.
公司地址 3027 Townsgate Road, Suite 300, Westlake Village, CA, USA, 91361
電話號碼 +1 805 418-5006
傳真號碼 --
公司網頁 https://www.arcutis.com
員工數量 354
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Patrick E. Burnett, M.D. Executive Vice President and Chief Medical Officer 美元 504.20K 29/04/2025
Mr. Masaru Matsuda, J.D. Senior Vice President, General Counsel and Corporate Secretary 美元 465.47K 29/04/2025
Mr. Todd Franklin Watanabe Director, President and Chief Executive Officer 美元 660.87K 25/02/2026
Mr. L. Todd Edwards Executive Vice President and Chief Commercial Officer 美元 516.42K 29/04/2025
Ms. Latha Vairavan Principal Accounting Officer, Senior Vice President and Chief Financial Officer -- 25/02/2026
 
董事會成員
董事會 職務 更新日期
Mr. Keith R. Leonard, Jr Chairman of the Board 25/02/2026
Mr. Patrick J. Heron Independent Director 25/02/2026
Ms. Halley E. Gilbert Independent Director 25/02/2026
Ms. Terrie Curran Independent Director 25/02/2026
Mr. Todd Franklin Watanabe Director, President and Chief Executive Officer 25/02/2026
Dr. Howard G. Welgus, M.D. Independent Director 25/02/2026
Ms. Sue-Jean Lin Independent Director 25/02/2026
Ms. Neha Krishnamohan Independent Director 25/02/2026
Mr. Amit D. Munshi Director 25/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:49)
代號 名稱 佔比% 持有日期
BIBProShares Ultra Nasdaq Biotechnology0.005%27/02/2026
ITWOProShares Russell 2000 High Income ETF0.004%27/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.004%28/02/2026
FSMLFranklin Small Cap Enhanced ETF0.004%28/02/2026
MMSCFirst Trust Multi-Manager Sm Cp Opps ETF0.004%26/02/2026
HELXFranklin Genomic Advancements ETF0.003%28/02/2026
BKSEBNY Mellon US Small Cap Core Equity ETF0.003%28/02/2026
RUSCRussell Inv U.S. Small Cap Equity ETF0.003%28/02/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.002%27/02/2026
TILTFlexShares Mstar US Mkt Factors Tilt ETF0.002%27/02/2026
RFLRInnovator U.S. Small Cp Mgd Flr ETF0.002%25/02/2026
ACSGAmerican Century Small Cp Gr Insgts ETF0.001%28/02/2026
PBSMInvesco PureBeta MSCI USA Small Cap ETF0.0003%31/05/2023
KBFRInnovator U.S. Small Cap Mgd 10 Bfr ETF0.0002%27/02/2026
HDGProShares Hedge Replication0.0001%27/02/2026
BBCVirtus LifeSci Biotech Clinical Trls ETF<0.000001%16/12/2025
CLSEConvergence Long/Short Equity ETF<0.000001%19/12/2025
FFTYInnovator IBD® 50 ETF<0.000001%20/01/2026
HKNDHumankind US Stock ETF<0.000001%24/11/2025
HYPGolden Eagle Dynamic Hypergrowth ETF<0.000001%03/02/2026
  1    2   3    4  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.